Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Microbiota and Lung Cancer. Opportunities and Challenges for Improving Immunotherapy Efficacy
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-24
DOI
10.3389/fonc.2020.568939
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment
- (2020) Andrea Botticelli et al. Journal of Translational Medicine
- Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems
- (2019) Mary Ajamian et al. PLoS One
- The microbiome and lung cancer
- (2019) Abhiram Maddi et al. Journal of Thoracic Disease
- Metabolomics in chronic lung diseases
- (2019) Shabarinath Nambiar et al. RESPIROLOGY
- The microbiome, cancer, and cancer therapy
- (2019) Beth A. Helmink et al. NATURE MEDICINE
- Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
- (2019) Chengcheng Jin et al. CELL
- The Microbiome in Lung Cancer Tissue and Recurrence-Free Survival
- (2019) Brandilyn A. Peters et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Dysbiosis Disrupts Gut Immune Homeostasis and Promotes Gastric Diseases
- (2019) Devinder Toor et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The diversity of gut microbiome is associated with favorable responses to anti-PD-1 immunotherapy in Chinese non-small cell lung cancer patients
- (2019) Yueping Jin et al. Journal of Thoracic Oncology
- Smoking and microbiome in oral, airway, gut and some systemic diseases
- (2019) Chunrong Huang et al. Journal of Translational Medicine
- Human Lung Microbiome on the Way to Cancer
- (2019) Olga V. Kovaleva et al. Journal of Immunology Research
- Gut microbiota and cancer: how gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy
- (2019) Stefania Gori et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Exploiting the Zonulin Mouse Model to Establish the Role of Primary Impaired Gut Barrier Function on Microbiota Composition and Immune Profiles
- (2019) Alba Miranda-Ribera et al. Frontiers in Immunology
- Prediction of response to anti-PD-1 therapy in patients with non-small-cell lung cancer by electronic nose analysis of exhaled breath
- (2019) R de Vries et al. ANNALS OF ONCOLOGY
- Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
- (2019) Luis Paz-Ares et al. LANCET
- Airway Microbiota Is Associated with Up-Regulation of the PI3K Pathway in Lung Cancer
- (2018) Jun-Chieh J Tsay et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer
- (2018) L Derosa et al. ANNALS OF ONCOLOGY
- The impact of the intestinal microbiota in therapeutic responses against cancer
- (2018) Anne-Gaëlle Goubet et al. COMPTES RENDUS BIOLOGIES
- Current landscape of immunotherapy for the treatment of metastatic non-small-cell lung cancer
- (2018) A. Pabani et al. Current Oncology
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
- (2018) Mark A. Socinski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Microbiome characteristics of induced sputum compared to bronchial fluid and upper airway samples
- (2018) Shi-qi An et al. PEDIATRIC PULMONOLOGY
- The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
- (2018) Laurence Zitvogel et al. SCIENCE
- Bacterial biogeography of adult airways in atopic asthma
- (2018) Juliana Durack et al. Microbiome
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Gut microbiota, dietary intakes and intestinal permeability reflected by serum zonulin in women
- (2018) S. Mörkl et al. EUROPEAN JOURNAL OF NUTRITION
- Evaluation of the airway microbiome in non-tuberculous mycobacteria
- (2018) Imran Sulaiman et al. EUROPEAN RESPIRATORY JOURNAL
- Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
- (2018) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
- (2018) Leora Horn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases
- (2018) Valentino Le Noci et al. Cell Reports
- Can the Sputum Microbiota Be a Biomarker that Predicts Mortality after Acute Exacerbations of COPD?
- (2018) Jun-Chieh J Tsay et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Lung inflammation and disease: A perspective on microbial homeostasis and metabolism
- (2018) Roberto Mendez et al. IUBMB LIFE
- The nutrition-gut microbiome-physiology axis and allergic diseases
- (2017) Craig McKenzie et al. IMMUNOLOGICAL REVIEWS
- Early Immune-Related Adverse Events and Association with Outcome in Advanced Non–Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study
- (2017) Shunsuke Teraoka et al. Journal of Thoracic Oncology
- PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project
- (2017) Fred R. Hirsch et al. Journal of Thoracic Oncology
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
- (2017) Julie R Brahmer et al. LANCET ONCOLOGY
- Anticancer effects of the microbiome and its products
- (2017) Laurence Zitvogel et al. NATURE REVIEWS MICROBIOLOGY
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- The intestinal barrier: a fundamental role in health and disease
- (2017) Maaike Vancamelbeke et al. Expert Review of Gastroenterology & Hepatology
- Desired Turbulence? Gut-Lung Axis, Immunity, and Lung Cancer
- (2017) Rea Bingula et al. Journal of Oncology
- Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study
- (2017) Lisa Lindheim et al. PLoS One
- Quantification of the smoking-associated cancer risk with rate advancement periods: meta-analysis of individual participant data from cohorts of the CHANCES consortium
- (2016) José Manuel Ordóñez-Mena et al. BMC Medicine
- The Basis of Oncoimmunology
- (2016) A. Karolina Palucka et al. CELL
- Metagenomics, Metatranscriptomics, and Metabolomics Approaches for Microbiome Analysis
- (2016) Vanessa Aguiar-Pulido et al. Evolutionary Bioinformatics
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions
- (2016) Sang Hoon Lee et al. LUNG CANCER
- The metabolomic detection of lung cancer biomarkers in sputum
- (2016) Simon J.S. Cameron et al. LUNG CANCER
- The intestinal epithelial barrier: a therapeutic target?
- (2016) Matthew A. Odenwald et al. Nature Reviews Gastroenterology & Hepatology
- Emerging pathogenic links between microbiota and the gut–lung axis
- (2016) Kurtis F. Budden et al. NATURE REVIEWS MICROBIOLOGY
- Functional Redundancy-Induced Stability of Gut Microbiota Subjected to Disturbance
- (2016) Andrés Moya et al. TRENDS IN MICROBIOLOGY
- The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases
- (2016) Samuel M. Gonçalves et al. Virulence
- Revised Estimates for the Number of Human and Bacteria Cells in the Body
- (2016) Ron Sender et al. PLOS BIOLOGY
- Metabolomics and Its Application to Acute Lung Diseases
- (2016) Kathleen A. Stringer et al. Frontiers in Immunology
- The lung microbiota in early rheumatoid arthritis and autoimmunity
- (2016) Jose U. Scher et al. Microbiome
- Correlation of the lung microbiota with metabolic profiles in bronchoalveolar lavage fluid in HIV infection
- (2016) Sushma K. Cribbs et al. Microbiome
- Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype
- (2016) Leopoldo N. Segal et al. Nature Microbiology
- Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center
- (2015) Troy Z. Horvat et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Regulation of lung immunity and host defense by the intestinal microbiota
- (2015) Derrick R. Samuelson et al. Frontiers in Microbiology
- Gut Microbial Metabolism Drives Transformation of Msh2-Deficient Colon Epithelial Cells
- (2014) Antoaneta Belcheva et al. CELL
- Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis
- (2014) Cynthia L. Sears et al. JOURNAL OF CLINICAL INVESTIGATION
- Development of a Prokaryotic Universal Primer for Simultaneous Analysis of Bacteria and Archaea Using Next-Generation Sequencing
- (2014) Shunsuke Takahashi et al. PLoS One
- Comparison of the Respiratory Microbiome in Healthy Nonsmokers and Smokers
- (2013) Alison Morris et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The role of the bacterial microbiome in lung disease
- (2013) Robert P Dickson et al. Expert Review of Respiratory Medicine
- Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2
- (2009) A. Tripathi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bacterial Community Variation in Human Body Habitats Across Space and Time
- (2009) E. K. Costello et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started